Last updated: 2026-09-23 20:13:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
NewGenIvf Group Limited (NIVF) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $0.59, with a market capitalization of $1.74M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.56 to $1,539.00. This page covers its latest market performance, valuation, price trends and company information.
$1.74M | |
$0.80 | |
$1,771,200.00 | |
$0.56 | |
$0.81 | |
758.86K | |
179.22K | |
-- | |
$1,539.00 | |
$0.56 | |
-- | |
-- |
NewGenIvf Group Limited (NIVF) is trading at $0.64 in after-hours trading as of 2026-09-23 20:11:00, down 21.96% ($0.18) from the regular-session close of $0.81.
After-hours trading shows how investors are pricing NIVF after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, NewGenIvf Group Limited (NIVF) moved from $0.93 to $0.59, representing a decline of 36.50% ($0.34).
The stock traded between $0.56 and $1.06 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 123.16 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.0%
NIVF is currently trading at $0.59, placing it 0.0% of the way from its 52-week low of $0.56 to its 52-week high of $1,539.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
NewGenIvf Group Ltd is a tech-forward, diversified, multi-jurisdictional entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The company offers two services, namely: in vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and fertility referral services, like surrogacy and ancillary caring services. It derives maximum revenue from in vitro fertilization (IVF) treatment service. Its Geographical presence is in China / HK SAR, Thailand, Cambodia, U.S and Kyrgyzstan. The company derives maximum revenue from Kyrgyzstan.
| Employees | 87 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of NewGenIvf Group Limited (NIVF) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.